Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
4 raisons identifiées
Plateau technique de référence
Assistance publique – Hôpitaux de Paris (APHP) — équipements et expertise pointus pour les cas complexes
Auteur de référence en rhumatologie
28 articles scientifiques publiés — un praticien à la pointe de la recherche
Encadrant universitaire
Forme la prochaine génération de rhumatologues (6 thèses dirigées)
Délais de RDV courts dans la région
336.2 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Épidémiologie et immunité muqueuse spécifique au cours de l'infection à Papillomavirus Humains : implications pour la prévention des cancers associés
2019Doctorant·e : Ralph-Sydney Mboumba Bouassa
Groupes à Haut Risque du VIH en République Centrafricaine : Classification et interventions précoces
2016Doctorant·e : Jean de Dieu Longo
Rôle des anticorps naturels et des IgA sécrétoires (SIgA) dans la transmission du VIH lors de l'allaitement
2007Doctorant·e : Mary-Sophie Requena
Effet différentiel des produits finaux de glycosylation avancée ou AGE (Advanced Glycation End products) sur l’infection par le virus de l’immunodéficience humaine de type 1 (VIH-1) : évaluation des molécules à visée microbicides
2007Doctorant·e : Nadine El Ghotmi-Nasreddine
Immunité innée muqueuse contre le VIH : anticorps naturels et facteurs humoraux solubles
2006Doctorant·e : Jobin Eslahpazir Esfandabadi
Interactions entre le VIH-1 et l' herpes simplex de type 2 dans le microenvironnement cellulaire et génital
2005Doctorant·e : Jérôme Le Goff
Source theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
49
49 articles ont été cités au moins 49fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
10 625
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
363
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
189
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Délégation Paris 5 · Université Paris Cité · Hôpital Européen Georges-Pompidou
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
TRANSLACOL project: Nodal human papillomavirus tumoral DNA detection by ddPCR for survival prediction in early cervical cancer patients without pelvic lymph node invasion
2023ArticleJournal of Clinical Virology
HPV Molecular Genotyping as a Differential Diagnosis Tool in Cervical Cancer Metastasis
2023ArticleJournal of Personalized Medicine
Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab
2022ArticleAmerican Journal of Transplantation
Circulating Ubiquitous RNA, A Highly Predictive and Prognostic Biomarker in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients
2022ArticleClinical Infectious Diseases
Episomal HPV16 responsible for aggressive and deadly metastatic anal squamous cell carcinoma evidenced in peripheral blood
2021ArticleScientific Reports
Correction: High Prevalence of Anal Oncogenic Human Papillomavirus Infection in Young Men Who Have Sex with Men Living in Bamako, Mali
2021ArticleInfectious Agents and Cancer
High Prevalence of Anal Oncogenic Human Papillomavirus Infection in Young Men Who Have Sex with Men Living in Bamako, Mali
2021ArticleInfectious Agents and Cancer
No SARS-CoV-2 reinfection among staff health-care workers: Prospective hospital-wide screening during the first and second waves in Paris
2021ArticleJournal of Clinical Virology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
GHU APHP CUP SITE G POMPIDOU HEGP
20 R LEBLANC, 75908 PARIS CEDEX 15
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
Abstract Background Coronavirus disease 2019 (COVID-19) is a global public health problem that has already caused more than 662 000 deaths worldwide. Although the clinical manifestations of COVID-19 are dominated by respiratory symptoms, some patients present other severe damage such as cardiovascular, renal and liver injury, and/or multiple organ failure, suggesting a spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in blood. Recent ultrasensitive polymerase chain reaction (PCR) technology now allows absolute quantification of nucleic acids in plasma. We intend to use the droplet-based digital PCR technology to obtain sensitive detection and precise quantification of plasma SARS-CoV-2 viral load (SARS-CoV-2 RNAemia) in hospitalized COVID-19 patients. Methods Fifty-eight consecutive COVID-19 patients with pneumonia 8 to 12 days after onset of symptoms and 12 healthy controls were analyzed. Disease severity was categorized as mild to moderate in 17 patients, severe in 16, and critical in 26. Plasma SARS-CoV-2 RNAemia was quantified by droplet digital Crystal Digital PCR next-generation technology (Stilla Technologies, Villejuif, France). Results Overall, SARS-CoV-2 RNAemia was detected in 43 (74.1%) patients. Prevalence of positive SARS-CoV-2 RNAemia correlated with disease severity, ranging from 53% in mild-to-moderate patients to 88% in critically ill patients (P = .036). Levels of SARS-CoV-2 RNAemia were associated with severity (P = .035). Among 9 patients who experienced clinical deterioration during follow-up, 8 had positive SARS-CoV-2 RNAemia at baseline, whereas only 1 critical patient with undetectable SARS-CoV-2 RNAemia at the time of analysis died at day 27. Conclusion SARS-CoV-2 RNAemia measured by droplet-based digital PCR constitutes a promising prognosis biomarker in COVID-19 patients.
BMC infectious diseases · 2020
Abstract Background HIV self-testing (HIVST) can be performed using directly assisted and unassisted approaches in facilities or communities to reach different populations. The aim of this study was to compare the practicability and effectiveness of the two delivery approaches for HIVST, unassisted HIVST (UH) and directly assisted HIVST (DAH), in the field setting of Kisangani, the Democratic Republic of the Congo (DRC). Methods A randomized (1:1), non-blinded, non-inferiority trial using a blood-based and facility-based HIVST method was carried out in four facilities in Kisangani, the DRC, targeting populations at high risk for HIV infection. The primary outcome was the difference in the practicability of the HIV self-test between the two arms. Practicability was defined as successfully performing the test and correctly interpreting the result. Requests for assistance, positivity rate, linkage to care, and willingness to buy an HIV self-test kit constituted the secondary outcomes for HIVST effectiveness. The adjusted risk ratios (aRRs) were calculated using Poisson regression. Results The rate of successfully performing the test was same (93.2%) in the UH and DAH arms. The rate of correctly interpreting the results was 86.9% in the UH arm versus 93.2% in the DAH arm, for a difference of − 6.3%. After the follow-up 72 h later, participants in the UH arm had a significantly lower chance of correctly interpreting the test results than those in the DAH arm (aRR: 0.60; P = 0.019). Although the positivity rate was 3.4% among the participants in the DAH arm and 1.7% among those in the UH arm, no significant differences were found between the two arms in the positivity rate, requests for assistance, and linkage to care. Willingness to buy an HIV self-test was higher in the UH arm than in the DAH arm (92.3% versus 74.1%; aRR: 4.20; P < 0.001). Conclusion The results of this study indicate that UH is as practicable and effective as DAH among individuals at high risk for HIV infection in Kisangani, the DRC. However, additional support tools need to be assessed to improve the interpretation of the self-test results when using the UH approach. Trial registration PACTR201904546865585. Registered 03 April 2019 - Retrospectively registered, https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=6032
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Tropical medicine and infectious disease · 2025 · Journal Article
Muwonga Tukisadila J, Mboumba Bouassa RS, Tonen-Wolyec S, Loemba H, et al.
The Pan African medical journal · 2023 · Observational Study
Rafaï CD, Heredeibona LS, Lango-Yaya E, Belizaire RD, et al.
Journal of personalized medicine · 2023 · Journal Article
Montero-Macías R, Coronado PJ, Robillard N, Veyer D, et al.
The Pan African medical journal · 2022 · Multicenter Study
Mossoro-Kpinde CD, Kalla GCM, Baguida-Bokia C, Sombot-Ndicki S, et al.
The Pan African medical journal · 2022 · Journal Article
Mossoro-Kpinde CD, Bobossi C, Tonen-Wolyec S, Kalla GCM, et al.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2021 · Journal Article
Wack M, Péré H, Demory-Guinet N, Kassis-Chikhani N, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021 · Journal Article
Veyer D, Kernéis S, Poulet G, Wack M, et al.
Diagnostic microbiology and infectious disease · 2021 · Comparative Study
Mboumba Bouassa RS, Tonen-Wolyec S, Rodary J, Bélec L
Frontiers in medicine · 2021 · Journal Article
Tonen-Wolyec S, Kayembe Tshilumba C, Batina-Agasa S, Tagoto Tepungipame A, et al.
Journal of medical virology · 2021 · Journal Article
Fitoussi F, Dupont R, Tonen-Wolyec S, Bélec L
Journal of medical virology · 2021 · Journal Article
Mboumba Bouassa RS, Péré H, Tonen-Wolyec S, Longo JD, et al.
Stem cell reviews and reports · 2021 · Case Reports
Szwebel TA, Veyer D, Robillard N, Eshagh D, et al.
The Pan African medical journal · 2020 · Editorial
Nodjikouambaye ZA, Adawaye C, Yandai FH, Bélec L
Hematology (Amsterdam, Netherlands) · 2020 · Letter
Tonen-Wolyec S, Marini Djang'eing'a R, Kambale-Kombi P, Tshilumba CK, et al.
Diseases (Basel, Switzerland) · 2025 · Journal Article
Mboumba-Mboumba M, Mouinga-Ondeme A, Moussavou-Boundzanga P, Engone-Ondo JD, et al.
Public health in practice (Oxford, England) · 2022 · Journal Article
Longo JD, Woromogo SH, Diemer HS, Tékpa G, et al.
Infectious agents and cancer · 2021 · Published Erratum
Koyalta D, Mboumba Bouassa RS, Maiga AI, Balde A, et al.
Expert review of molecular diagnostics · 2026 · Journal Article
Mboumba Bouassa RS, Muwonga Tukisadila J, Loemba H, Belec L
Health science reports · 2025 · Journal Article
Abdoudaim MS, Bélec L, Ahmed MLCB, Baba NDM, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022 · Journal Article
Bruneau T, Wack M, Poulet G, Robillard N, et al.
Expert review of molecular diagnostics · 2026 · Journal Article
Mboumba Bouassa RS, Muwonga Tukisadila J, Loemba H, Belec L
Tropical medicine & international health : TM & IH · 2022 · Journal Article
Tonen-Wolyec S, Mbumba Lupaka DM, Batina-Agasa S, Mbopi Keou FX, et al.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022 · Case Reports
Morel A, Imbeaud S, Scemla A, Péré H, et al.
Nature communications · 2025 · Journal Article
Mabika-Obanda AKF, Ambounda Ledaga N, Ngou Milama K, Zang Obame V, et al.
BMC infectious diseases · 2020 · Journal Article
Tonen-Wolyec S, Kayembe Tshilumba C, Batina-Agasa S, Marini Djang'eing'a R, et al.
PloS one · 2024 · Journal Article
Mboumba Bouassa RS, Avala Ntsigouaye J, Lemba Tsimba PC, Nodjikouambaye ZA, et al.
PloS one · 2024 · Journal Article
Manzemu DG, Opara JPA, Kasai ET, Mumbere M, et al.
BMC infectious diseases · 2020 · Journal Article
Tonen-Wolyec S, Kayembe Tshilumba C, Batina-Agasa S, Marini Djang'eing'a R, et al.
Infectious agents and cancer · 2021 · Journal Article
Koyalta D, Mboumba Bouassa RS, Maiga AI, Balde A, et al.
Journal of immigrant and minority health · 2021 · Journal Article
Mboumba Bouassa RS, Gubavu C, Veyer D, Robin L, et al.